LeadIQ logo
Learn more at LeadIQ.com

Insights

Immunotherapy Market Growth Imugene is positioned in the rapidly growing immunotherapy market, offering innovative immunotherapies aiming to activate the immune system against tumors, which aligns with the increasing demand for effective cancer treatments.

Expert Cancer Development Team Imugene boasts a strong team of international cancer experts with a proven track record in developing successful cancer therapies, providing credibility and expertise that can be leveraged to attract potential investors and partners.

Diverse Product Pipeline With a diverse product pipeline encompassing multiple B-cell vaccine candidates and an oncolytic virotherapy targeting various cancers, Imugene has the potential to cater to a wide range of cancer types, offering multiple entry points for collaborations and licensing opportunities.

Strong Financial Position With a revenue range of $10M - 50M and recent funding of $3.3M, Imugene demonstrates financial stability and growth potential, making it an attractive partner for investors looking to invest in a promising biotechnology company.

Technologically Advanced Platform Imugene utilizes a range of advanced technologies such as Facebook Pixel, Squarespace Commerce, and Google Font API, showcasing a commitment to innovation that can be leveraged to create personalized marketing strategies and enhance customer engagement.

Similar companies to Imugene Limited

Imugene Limited Tech Stack

Imugene Limited uses 8 technology products and services including Facebook Pixel, Squarespace Commerce, Google Font API, and more. Explore Imugene Limited's tech stack below.

  • Facebook Pixel
    Analytics
  • Squarespace Commerce
    E-commerce
  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Choices
    Javascript Libraries
  • RSS
    Miscellaneous
  • Bootstrap
    UI Frameworks
  • YouTube
    Video Players

Media & News

Imugene Limited's Email Address Formats

Imugene Limited uses at least 1 format(s):
Imugene Limited Email FormatsExamplePercentage
FLast@imugene.comJDoe@imugene.com
47%
First.Last@imugene.comJohn.Doe@imugene.com
4%
FL@imugene.comJD@imugene.com
2%
FLast@imugene.comJDoe@imugene.com
47%

Frequently Asked Questions

Where is Imugene Limited's headquarters located?

Minus sign iconPlus sign icon
Imugene Limited's main headquarters is located at 37 Bligh St Suite 1006, Level 10 Sydney, New South Wales 2000 AU. The company has employees across 3 continents, including North AmericaOceaniaEurope.

What is Imugene Limited's phone number?

Minus sign iconPlus sign icon
You can contact Imugene Limited's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Imugene Limited's official website and social media links?

Minus sign iconPlus sign icon
Imugene Limited's official website is imugene.com and has social profiles on LinkedIn.

How much revenue does Imugene Limited generate?

Minus sign iconPlus sign icon
As of October 2024, Imugene Limited's annual revenue reached $35M.

What is Imugene Limited's SIC code NAICS code?

Minus sign iconPlus sign icon
Imugene Limited's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Imugene Limited have currently?

Minus sign iconPlus sign icon
As of October 2024, Imugene Limited has approximately 58 employees across 3 continents, including North AmericaOceaniaEurope. Key team members include Chief Medical Officer: P. W.Chief Operating Officer: B. G.Chief Medical Officer: M. M.. Explore Imugene Limited's employee directory with LeadIQ.

What industry does Imugene Limited belong to?

Minus sign iconPlus sign icon
Imugene Limited operates in the Biotechnology Research industry.

What technology does Imugene Limited use?

Minus sign iconPlus sign icon
Imugene Limited's tech stack includes Facebook PixelSquarespace CommerceGoogle Font APIjQueryChoicesRSSBootstrapYouTube.

What is Imugene Limited's email format?

Minus sign iconPlus sign icon
Imugene Limited's email format typically follows the pattern of . Find more Imugene Limited email formats with LeadIQ.

How much funding has Imugene Limited raised to date?

Minus sign iconPlus sign icon
As of October 2024, Imugene Limited has raised $3.3M in funding. The last funding round occurred on Sep 03, 2024 for $3.3M.

When was Imugene Limited founded?

Minus sign iconPlus sign icon
Imugene Limited was founded in 2013.
Imugene Limited

Imugene Limited

Biotechnology ResearchNew South Wales, Australia51-200 Employees

Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and other immunotherapies. Our product pipeline includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with standard of care drugs and emerging immunotherapies. We are supported by a leading team of international cancer experts with extensive experience in developing new cancer therapies with many approved for sale and marketing for global markets. ASX: IMU

Section iconCompany Overview

Headquarters
37 Bligh St Suite 1006, Level 10 Sydney, New South Wales 2000 AU
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $3.3M

    Imugene Limited has raised a total of $3.3M of funding over 3 rounds. Their latest funding round was raised on Sep 03, 2024 in the amount of $3.3M.

  • $10M$50M

    Imugene Limited's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $3.3M

    Imugene Limited has raised a total of $3.3M of funding over 3 rounds. Their latest funding round was raised on Sep 03, 2024 in the amount of $3.3M.

  • $10M$50M

    Imugene Limited's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.